Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer

被引:18
|
作者
Alibek, Kenneth [1 ,2 ]
Irving, Stephanie [1 ]
Sautbayeva, Zarina [1 ]
Kakpenova, Ainur [1 ]
Bekmurzayeva, Aliya [1 ]
Baiken, Yeldar [1 ]
Imangali, Nurgul [3 ]
Shaimerdenova, Madina [3 ]
Mektepbayeva, Damel [1 ]
Balabiyev, Arnat [1 ]
Chinybayeva, Aizada [1 ]
机构
[1] Nazarbayev Univ, Nazarbayev Univ Res & Innovat Syst NURIS, Astana 010000, Kazakhstan
[2] Natl Med Holding, Astana 010000, Kazakhstan
[3] Nazarbayev Univ, Sch Sci & Technol, Astana 010000, Kazakhstan
来源
INFECTIOUS AGENTS AND CANCER | 2014年 / 9卷
关键词
Bcl-2; Bcl-xL; Herpesviruses; Human T-lymphotropic virus 1; Human papillomavirus; Hepatitis C virus; Apoptosis; Signaling pathways; Tumor suppressor genes; Cancer; EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; HUMAN-PAPILLOMAVIRUS TYPE-16; PROTEASOME-MEDIATED DEGRADATION; PRIMARY EFFUSION LYMPHOMA; GROWTH-FACTOR RECEPTOR; I TAX PROTEIN; KAPOSIS-SARCOMA; INHIBITS APOPTOSIS; HTLV-I;
D O I
10.1186/1750-9378-9-44
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Bcl proteins play a critical role in apoptosis, as mutations in family members interfere with normal programmed cell death. Such events can cause cell transformation, potentially leading to cancer. Recent discoveries indicate that some viral proteins interfere with Bcl proteins either directly or indirectly; however, these data have not been systematically described. Some viruses encode proteins that reprogramme host cellular signalling pathways controlling cell differentiation, proliferation, genomic integrity, cell death, and immune system recognition. This review analyses and summarises the existing data and discusses how viral proteins interfere with normal pro-and anti-apoptotic functions of Bcl-2 and Bcl-xL. Particularly, this article focuses on how viral proteins, such as Herpesviruses, HTLV-1, HPV and HCV, block apoptosis and how accumulation of such interference predisposes cancer development. Finally, we discuss possible ways to prevent and treat cancers using a combination of traditional therapies and antiviral preparations that are effective against these viruses.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer
    Kenneth Alibek
    Stephanie Irving
    Zarina Sautbayeva
    Ainur Kakpenova
    Aliya Bekmurzayeva
    Yeldar Baiken
    Nurgul Imangali
    Madina Shaimerdenova
    Damel Mektepbayeva
    Arnat Balabiyev
    Aizada Chinybayeva
    Infectious Agents and Cancer, 9
  • [2] Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
    Westhoff, Mike-Andrew
    Schuler-Ortoli, Marie
    Zerrinius, Daniela
    Hadzalic, Amina
    Schuster, Andrea
    Strobel, Hannah
    Scheuerle, Angelika
    Wong, Tiana
    Wirtz, Christian Rainer
    Debatin, Klaus-Michael
    Peraud, Aurelia
    PHARMACEUTICALS, 2022, 15 (01)
  • [3] Bcl-xL and bcl-2 proteins in melanoma progression and UVB-induced apoptosis
    Hong, Z
    Rosdahl, I
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (03) : 661 - 666
  • [4] Regulation of Mammalian Target of Rapamycin Complex 1 by Bcl-2 and Bcl-XL Proteins
    Zou, Huafei
    Lai, Yumei
    Zhao, Xuwen
    Yan, Gonghong
    Ma, Dongzhu
    Cardenes, Nayra
    Shiva, Sruti
    Liu, Yongjian
    Bai, Xiaochun
    Jiang, Yong
    Jiang, Yu
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (40) : 28824 - 28830
  • [5] Towards the next generation of dual Bcl-2/Bcl-xL inhibitors
    Varnes, Jeffrey G.
    Gero, Thomas
    Huang, Shan
    Diebold, R. Bruce
    Ogoe, Claude
    Grover, Paul T.
    Su, Mei
    Mukherjee, Prasenjit
    Saeh, Jamal Carlos
    MacIntyre, Terry
    Repik, Galina
    Dillman, Keith
    Byth, Kate
    Russell, Daniel John
    Ioannidis, Stephanos
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (14) : 3026 - 3033
  • [6] Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists
    Perez, Heidi L.
    Banfi, Patrizia
    Bertrand, Jay
    Cai, Zhen-Wei
    Grebinski, James W.
    Kim, Kyoung
    Lippy, Jonathan
    Modugno, Michele
    Naglich, Joseph
    Schmidt, Robert J.
    Tebben, Andrew
    Vianello, Paola
    Wei, Donna D.
    Zhang, Liping
    Galvani, Arturo
    Lombardo, Louis J.
    Borzilleri, Robert M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 3946 - 3950
  • [7] The Role of Bcl-xL Protein in Viral Infections
    Wyzewski, Zbigniew
    switlik, Weronika
    Mielcarska, Matylda Barbara
    Gregorczyk-Zboroch, Karolina Paulina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 16
  • [8] Unknotting the roles of Bcl-2 and Bcl-xL in cell death
    Kim, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 333 (02) : 336 - 343
  • [9] Dual targeting Bcl-2 and Bcl-xL augments osteosarcoma response to doxorubicin
    Cao, Chuanhua
    Pei, Yu
    Yu, Haiying
    Qi, Huixiong
    JOURNAL OF CHEMOTHERAPY, 2024, 36 (02) : 156 - 166
  • [10] Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck
    Pena, JC
    Thompson, CB
    Recant, W
    Vokes, EE
    Rudin, CM
    CANCER, 1999, 85 (01) : 164 - 170